Neuroprotective and neurodegenerative effects of the chronic expression of tumor necrosis factor α in the nigrostriatal dopaminergic circuit of adult mice.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Experimental Neurology

• Publication date

  2011-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.expneurol.2010.11.010PMID 21093436
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Parkinson's disease].

  2022cited by this paper
• Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation.

  2010influential reference
• Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention.

  2010cited by this paper
• Neuroinflammation in Parkinson's disease: a target for neuroprotection?

  2009cited by this paper
• Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy?

  2008cited by this paper
• Glial reactions in Parkinson's disease

  2008cited by this paper
• Early inhibition of TNFα increases 6-hydroxydopamine-induced striatal degeneration

  2007cited by this paper
• Neuroinflammatory mechanisms in Parkinson's disease: potential environmental triggers, pathways, and targets for early therapeutic intervention.

  2007cited by this paper
• Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications.

  2007cited by this paper
• The pathogenesis of cell death in Parkinson's disease – 2007

  2007cited by this paper
• Inflammation as a causative factor in the aetiology of Parkinson's disease

  2007cited by this paper
• Neuronal NOS‐mediated nitration and inactivation of manganese superoxide dismutase in brain after experimental and human brain injury

  2006cited by this paper
• Blocking Soluble Tumor Necrosis Factor Signaling with Dominant-Negative Tumor Necrosis Factor Inhibitor Attenuates Loss of Dopaminergic Neurons in Models of Parkinson's Disease

  2006cited by this paper
• Inflammatory responses of the substantia nigra after acute hypoxia in neonatal rats.

  2006cited by this paper
• Genetics of Parkinson disease: paradigm shifts and future prospects

  2006cited by this paper
• Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor‐α

  2006influential reference
• Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1beta in the substantia nigra.

  2006cited by this paper
• The pathogenesis of cell death in Parkinson's disease

  2006cited by this paper
• Intra-parenchymal injection of tumor necrosis factor-alpha and interleukin 1-beta produces dopamine neuron loss in the rat.

  2005cited by this paper
• Increased plasma levels of TNF-α but not of IL1-β in MPTP-treated monkeys one year after the MPTP administration

  2005cited by this paper
• Intra-parenchymal injection of tumor necrosis factor-α and interleukin 1-β produces dopamine neuron loss in the rat

  2005cited by this paper
• Increased plasma levels of TNF-alpha but not of IL1-beta in MPTP-treated monkeys one year after the MPTP administration.

  2005cited by this paper
• Differential effects of interleukin-1beta on neurotoxicity, cytokine induction and glial reaction in specific brain regions.

  2005cited by this paper
• Inflammatory process in Parkinson's disease: role for cytokines.

  2005cited by this paper
• Reversible demyelination, blood-brain barrier breakdown, and pronounced neutrophil recruitment induced by chronic IL-1 expression in the brain.

  2004cited by this paper
• Combined toxicity of prenatal bacterial endotoxin exposure and postnatal 6-hydroxydopamine in the adult rat midbrain.

  2004cited by this paper
• Caspase-11 Mediates Inflammatory Dopaminergic Cell Death in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson's Disease

  2004cited by this paper
• Study of cytokine induced neuropathology by high resolution proton NMR spectroscopy of rat urine

  2004cited by this paper
• Regional variations and age-related changes in nitric oxide synthase and arginase in the sub-regions of the hippocampus.

  2003cited by this paper
• The Role of Glial Reaction and Inflammation in Parkinson's Disease

  2003cited by this paper
• The mouse brain in stereotaxic coordinates

  2003influential reference
• Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: Implications for Parkinson's disease

  2002influential reference
• Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease

  2002cited by this paper
• The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-alpha, IL-1beta and IFN-gamma.

  2002cited by this paper
• The role of leukocytes following cerebral ischemia: pathogenic variable or bystander reaction to emerging infarct?

  2002cited by this paper
• Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-alpha, interleukin-1beta, and nitric oxide.

  2002cited by this paper
• Role of TNF-alpha receptors in mice intoxicated with the parkinsonian toxin MPTP.

  2002influential reference
• A role for tumor necrosis factor alpha in death of dopaminergic neurons following neural transplantation.

  2002cited by this paper
• In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain

  2002cited by this paper
• Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration.

  2002cited by this paper
• Neural‐Immune Interactions in Health and Disease

  2002cited by this paper
• Differential induction of interleukin-1beta and tumour necrosis factor-alpha may account for specific patterns of leukocyte recruitment in the brain.

  2002influential reference
• Role of TNF-α Receptors in Mice Intoxicated with the Parkinsonian Toxin MPTP

  2002influential reference
• The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh‐TNF‐α, IL‐1β and IFN‐γ

  2002cited by this paper
• Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-α, interleukin-1β, and nitric oxide

  2002cited by this paper
• A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus

  2001cited by this paper
• Tumor Necrosis Factor-α Selectively InducesMnSOD Expression via Mitochondria-to-Nucleus Signaling, whereas Interleukin-1β Utilizes an Alternative Pathway*

  2001cited by this paper
• Tumor Necrosis Factor α Is Toxic to Embryonic Mesencephalic Dopamine Neurons

  2001cited by this paper
• Defective CD4T cell priming and resistance to experimental autoimmune encephalomyelitis in TNF-deficient mice due to innate immune hypo-responsiveness.

  2001cited by this paper
• Tumor necrosis factor alpha is toxic to embryonic mesencephalic dopamine neurons.

  2001cited by this paper
• TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.

  2001cited by this paper
• Tumor necrosis factor-alpha selectively induces MnSOD expression via mitochondria-to-nucleus signaling, whereas interleukin-1beta utilizes an alternative pathway.

  2001influential reference
• Neuroprotection through Delivery of Glial Cell Line-Derived Neurotrophic Factor by Neural Stem Cells in a Mouse Model of Parkinson's Disease

  2001cited by this paper
• Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum.

  2001cited by this paper
• Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease.

  2000influential reference
• The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system.

  2000cited by this paper
• Tumor necrosis factor-alpha induces neuronal death by silencing survival signals generated by the type I insulin-like growth factor receptor.

  2000cited by this paper
• Increase in level of tumor necrosis factor-alpha in 6-hydroxydopamine-lesioned striatum in rats is suppressed by immunosuppressant FK506.

  2000cited by this paper
• Cytokines in Parkinson's disease.

  2000cited by this paper
• Tumor Necrosis Factor‐α Induces Neuronal Death by Silencing Survival Signals Generated by the Type I Insulin‐Like Growth Factor Receptor

  2000cited by this paper
• Lentiviral vectors as a gene delivery system in the mouse midbrain: cellular and behavioral improvements in a 6-OHDA model of Parkinson's disease using GDNF.

  2000cited by this paper
• Nitric oxide, glial cells and neuronal degeneration in parkinsonism.

  2000cited by this paper
• Regional Difference in Susceptibility to Lipopolysaccharide-Induced Neurotoxicity in the Rat Brain: Role of Microglia

  2000cited by this paper
• FcεRII/CD23 Is Expressed in Parkinson’s Disease and Induces, In Vitro, Production of Nitric Oxide and Tumor Necrosis Factor-α in Glial Cells

  1999cited by this paper
• Glial cell line-derived neurotrophic factor protects midbrain dopamine neurons from the lethal action of the weaver gene: a quantitative immunocytochemical study.

  1999cited by this paper
• Anti-death properties of TNF against metabolic poisoning: mitochondrial stabilization by MnSOD.

  1999influential reference
• Adenoviral vectors: prospects for gene delivery to the central nervous system

  1999cited by this paper
• FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.

  1999cited by this paper
• TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study

  1999cited by this paper
• TNF neutralization in MS

  1999cited by this paper
• Cytokine-induced acute inflammation in the brain and spinal cord.

  1999cited by this paper
• A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide.

  1999cited by this paper
• Lipopolysaccharide Intranigral Injection Induces Inflammatory Reaction and Damage in Nigrostriatal Dopaminergic System

  1998cited by this paper
• Parkinson's disease. First of two parts.

  1998cited by this paper
• First of two parts

  1997cited by this paper
• Neural-immune interactions in health and disease.

  1997influential reference
• Regulation of GDNF expression in cultured astrocytes by inflammatory stimuli

  1997cited by this paper
• TNF-α expressed in the brain of transgenic mice lowers central tyroxine hydroxylase immunoreactivity and alters grooming behavior

  1997cited by this paper
• Dopaminergic Neurons Protected from Degeneration by GDNF Gene Therapy

  1997influential reference
• Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease.

  1997cited by this paper
• Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2

  1996cited by this paper
• Microglia: a sensor for pathological events in the CNS.

  1996cited by this paper
• Recombinant Human Adenovirus with Rat MIP‐2 Gene Insertion Causes Prolonged PMN Recruitment to the Murine Brain

  1996cited by this paper
• Protocols for gene transfer in neuroscience : towards gene therapy of neurological disorders

  1996cited by this paper
• Functional recovery in parkinsonian monkeys treated with GDNF

  1996cited by this paper
• Efficient gene activation in mammalian cells by using recombinant adenovirus expressing site-specific Cre recombinase.

  1995cited by this paper
• Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain

  1995cited by this paper
• Corticosterone modulates interleukin-evoked fever in the rat.

  1994cited by this paper
• Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease.

  1994cited by this paper
• Emergence of Early Region 1-Containing Replication-Competent Adenovirus in Stocks of Replication-Defective Adenovirus Recombinants (ΔE1 + ΔE3) During Multiple Passages in 293 Cells

  1994cited by this paper
• Neurotoxic effects of tumor necrosis factor alpha in primary human neuronal cultures are mediated by activation of the glutamate AMPA receptor subtype: implications for AIDS neuropathogenesis.

  1993cited by this paper
• An adenovirus vector for gene transfer into neurons and glia in the brain

  1993cited by this paper
• The Biological Role of Truncated Insulin‐like Growth Factor‐1 and the Tripeptide GPE in the Central Nervous System a

  1993influential reference
• Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain.

  1990cited by this paper
• Expression patterns of the homeo box-containing genes En-1 and En-2 and the proto-oncogene int-1 diverge during mouse development.

  1988cited by this paper

• Cortical White and Grey Matter Volume Differences Associated with Plasma Cytokine and Chemokine Levels in PLWH in Cape Town

  2025cites this paper
• Differentiation and regulation of CD4+ T cell subsets in Parkinson’s disease

  2024cites this paper
• Dose-Ranging Effects of the Intracerebral Administration of Atsttrin in Experimental Model of Parkinson’s Disease Induced by 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Mice

  2024cites this paper
• Identification of immune-related hub genes in spinal cord injury

  2024cites this paper
• Beneficial effects of ferulic acid in streptozotocin-induced diabetic neuropathy in male Wistar rats

  2024cites this paper
• Oxidative stress involvement in the molecular pathogenesis and progression of multiple sclerosis: a literature review

  2024cites this paper
• The Dual Role of Survival Genes in Neurons and Cancer Cells: a Strategic Clinical Application of DX2 in Neurodegenerative Diseases and Cancer

  2024cites this paper
• Activation of TNF Receptor 2 Improves Synaptic Plasticity and Enhances Amyloid-β Clearance in an Alzheimer’s Disease Mouse Model with Humanized TNF Receptor 2

  2023cites this paper
• A systematic review and meta-analysis of inflammatory biomarkers in Parkinson’s disease

  2023cites this paper
• Evaluation of the therapeutic potential of cerebrolysin and/or lithium in the male Wistar rat model of Parkinson’s disease induced by reserpine

  2023cites this paper
• Molecular mechanisms of neuroprotective offerings by rosmarinic acid against neurodegenerative and other CNS pathologies

  2023cites this paper
• Cytokine activity in Parkinson’s disease

  2023cites this paper
• Anti-Inflammatory Properties of the SGLT2 Inhibitor Empagliflozin in Activated Primary Microglia

  2022cites this paper
• Naringin Attenuates the Diabetic Neuropathy in STZ-Induced Type 2 Diabetic Wistar Rats

  2022cites this paper
• Emerging roles of IL-34 in neurodegenerative and neurological infectious disease

  2021cites this paper
• Proinflammatory Cytokines and Chemokines are Related to MRI Measures of White and Gray Matter in HIV Infection

  2021cites this paper
• Can Toxoplasma gondii Pave the Road for Dementia?

  2020cites this paper
• Aging and MPTP Sensitivity Depend on Molecular and Ultrastructural Signatures of Astroglia and Microglia in Mice Substantia Nigra

  2020cites this paper
• Cytokine-, Neurotrophin-, and Motor Rehabilitation-Induced Plasticity in Parkinson's Disease

  2020cites this paper
• P2X4R Overexpression Upregulates Interleukin-6 and Exacerbates 6-OHDA-Induced Dopaminergic Degeneration in a Rat Model of PD

  2020cites this paper
• Parkinson’s Disease With Depression: The Correlations Between Neuroinflammatory Factors and Neurotransmitters in Cerebrospinal Fluid

  2020influential citation
• TNFα inhibitors as targets for protective therapies in MSA: a viewpoint

  2019cites this paper
• Acute Neuroinflammatory Response in the Substantia Nigra Pars Compacta of Rats after a Local Injection of Lipopolysaccharide

  2018cites this paper
• A New Venue of TNF Targeting

  2018cites this paper
• Forced exercise attenuates neuropathic pain in chronic constriction injury of male rat: an investigation of oxidative stress and inflammation

  2017cites this paper
• Glutaredoxin-1 As A Therapeutic Target In Neurodegenerative Inflammation

  2017cites this paper
• Parkinson's disease: Microglial/macrophage-induced immunoexcitotoxicity as a central mechanism of neurodegeneration

  2017cites this paper
• Investigation into pathological neuronal-myeloid cell interactions and rescue of hyper-reactive immune responses in Huntington's disease

  2017cites this paper
• Upregulation of Glutaredoxin-1 Activates Microglia and Promotes Neurodegeneration: Implications for Parkinson's Disease

  2016cites this paper
• Desarrollo del epéndimo y subepéndimo en modelos animales en condiciones normales y en la hidrocefalia congénita

  2016cites this paper
• Major histocompatibility complex expression in a rotenone model of Parkinson's disease in rats

  2016cites this paper
• Procesos Neuropatológicos Comunes Asociados a las Paredes Ventriculares en la Hidrocefalia Congénita Humana

  2016cites this paper
• Altered Expression Patterns of Inflammation-Associated and Trophic Molecules in Substantia Nigra and Striatum Brain Samples from Parkinson's Disease, Incidental Lewy Body Disease and Normal Control Cases

  2016cites this paper
• TNF-α regulates miRNA targeting mitochondrial complex-I and induces cell death in dopaminergic cells.

  2015cites this paper
• TNF-dependent regulation and activation of innate immune cells are essential for host protection against cerebral tuberculosis

  2015cites this paper
• Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study

  2015cites this paper
• Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study Pascal F. DurrenbergerFrancesca S. FernandoSamira N. KashefiTim P. BonnertDanielle Seilhean • Brahim Nait-OumesmarAndrea SchmittPeter J. Gebicke-HaerterPeter FalkaiEdna Grunblatt • Miklos

  2014cites this paper
• Minocycline attenuates brain tissue levels of TNF-α produced by neurons after prolonged hypothermic cardiac arrest in rats.

  2014cites this paper
• Transient transfection of human CDNF gene reduces the 6-hydroxydopamine-induced neuroinflammation in the rat substantia nigra

  2014cites this paper
• An Adaptive Role of TNFα in the Regulation of Striatal Synapses

  2014cites this paper
• New drug treatments show neuroprotective effects in Alzheimer's and Parkinson's diseases

  2014cites this paper
• The Inflammatory Cytokines in the Pathogenesis of ParkinsonâÂÂs Disease

  2014cites this paper
• Nanoencapsulation of the sasanquasaponin from Camellia oleifera, its photo responsiveness and neuroprotective effects

  2014cites this paper
• Increased levels of tumour necrosis factor alpha (TNFα) but not transforming growth factor‐beta 1 (TGFβ1) are associated with the severity of congenital hydrocephalus in the hyh mouse

  2014cites this paper
• Sildenafil Attenuates Inflammation and Oxidative Stress in Pelvic Ganglia Neurons after Bilateral Cavernosal Nerve Damage

  2014cites this paper
• Isolation of the sapogenin from defatted seeds of Camellia oleifera and its neuroprotective effects on dopaminergic neurons.

  2014cites this paper
• Anti-TNF Therapy: 20 Years from Our First Therapeutic Adventure

  2014cites this paper
• Chronic meningeal inflammation as a cause of cortical grey matter pathology in multiple sclerosis

  2014cites this paper
• Proinflammatory Chemical Signaling: Cytokines

  2014cites this paper
• Neuroinflammation in depression

  2014cites this paper
• P2X7‐dependent, but differentially regulated release of IL‐6, CCL2, and TNF‐α in cultured mouse microglia

  2014cites this paper
• Cytokines and Chemokines at the Crossroads of Neuroinflammation, Neurodegeneration, and Neuropathic Pain

  2013cites this paper
• Neuroprotective Activity of Peripherally Administered Liver Growth Factor in a Rat Model of Parkinson’s Disease

  2013cites this paper
• Immunity and inflammation in neurodegenerative diseases.

  2013cites this paper
• Interleukin-1β and tumor necrosis factor-α: reliable targets for protective therapies in Parkinson’s Disease?

  2013cites this paper
• Late blocking of peripheral TNF-α is ineffective after spinal cord injury in mice.

  2013cites this paper
• Dopamine receptor activation increases glial cell line-derived neurotrophic factor in experimental stroke.

  2013cites this paper
• Review Article Immunity and inflammation in neurodegenerative diseases

  2013cites this paper
• Inhibition of LPS-Induced Retinal Microglia Activation by Naloxone Does Not Prevent Photoreceptor Death

  2013cites this paper
• Pro-inflammatory cytokine; tumor-necrosis factor-alpha (TNF-α) inhibits astrocytic support of neuronal survival and neurites outgrowth

  2013cites this paper
• Elucidating the role of microglial group III metabotropic glutamate receptors in microglial inflammation : focus on Parkinson's disease and neuroprotection

  2013cites this paper
• Association of interleukin 2 (IL-2), interleukin 6 (IL-6), and TNF-alpha (TNFα) gene polymorphisms with paranoid schizophrenia in a Polish population.

  2013cites this paper
• Shared dysregulated pathways lead to Parkinson's disease and diabetes.

  2013cites this paper
• LRRK-2 as a Key Molecule Bridging Inflammation to Parkinson's Disease

  2013cites this paper
• Astrocyte-specific IKK2 activation in mice is sufficient to induce neuroinflammation but does not increase susceptibility to MPTP.

  2012cites this paper
• Serum Uric Acid in Patients with Parkinson’s Disease and Vascular Parkinsonism: A Cross-Sectional Study

  2012cites this paper
• HIV treatment: mechanisms of neurotoxicity and implications for targeted therapy

  2012cites this paper
• Inflammatory profile in schizophrenia and bipolar disorder

  2012cites this paper
• Chronic inorganic mercury exposure induces sex-specific changes in central TNFα expression: importance in autism?

  2011cites this paper
• Exposure to severe urban air pollution influences cognitive outcomes, brain volume and systemic inflammation in clinically healthy children.

  2011cites this paper
• TUMOR NECROSIS FACTOR ALPHA AND NON-INFLAMMATORY SENSITIZATION OF MASSETER MUSCLE NOCICEPTORS

  2011cites this paper
• Estudo da susceptibilidade de camundongos bons ou maus respondedores para inflamação aguda a neurotoxinas empregadas em modelos de Parkinson

  2011cites this paper
• The duality of TNF signaling outcomes in the brain: potential mechanisms?

  2011cites this paper
• Tumor Necrosis Factor-alpha and the Roles it Plays in Homeostatic and Degenerative Processes Within the Central Nervous System

  2011cites this paper
• New Drug Treatments Show Neuroprotective Effects in Alzheimer's and Parkinson's Diseases Invited Review

  year unknowncites this paper